Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000950170-25-033628 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | TEVA | Weiss Amir | CAO | M - OptEx | — | +5,179 | 10.4K | +100% | — |
| D | 2025-03-05 | 2025-03-03 | TEVA | Weiss Amir | CAO | M - OptEx | $0.00 | -5,179 | 10.4K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-03 | M | A | 5,179 | — | 10,358 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Derivative | Restricted Share Units | 2025-03-03 | M | D | 5,179 | $0.00 | 10,359 | D | — · — to — | 5,179 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 3, 2023, with 5,179 vested on each of March 3, 2024 and March 3, 2025, 5,179 vesting on March 3, 2026, and 5,180 vesting on March 3, 2027. |